Japan Generics Makers Set To Pounce On 2014 Patent Expirations
This article was originally published in PharmAsia News
Executive Summary
Sawai Pharmaceutical, Nichi-Iko Pharmaceutical, Towa Pharmaceutical and other Japan generics makers plan to spend about $482 million to take advantage of a slew of 2014 patent expirations.